Earnings · US stocks

Iovance Biotherapeutics Inc (IOVA) earnings

Iovance Biotherapeutics Inc published its quarterly report on 2026-11-05. The stock moved -6.09% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-05
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-11.03%—
3 days-6.09%—
7 days-10.80%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 4 of them. The stock rose in the 3 trading days after 4 of 8 reports (average +8.35%).

PublishedEPSEPS surprise3 days after30 days after30d vs index
2026-11-05-0.05+41.35%-6.09%——
2026-08-06-0.11+18.43%+47.47%+130.88%+131.81%
2026-05-07-0.19-23.78%-9.54%-4.40%-6.16%
2026-02-24-0.18-2.05%+31.14%+14.88%+18.27%
2025-11-06-0.25+2.85%+30.94%+35.91%+36.08%
2025-08-07-0.33-19.37%-15.53%-22.35%-27.32%
2025-05-08-0.36-52.33%+12.93%+16.72%+10.51%
2025-02-26-0.26+2.85%-24.49%-38.88%-31.15%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: IOVA · Stock news: IOVA

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.